FCRLA and ovarian carcinoma: In addition, FCRLA has been shown to participate in immune response‐related pathways in various malignancies, including advanced laryngeal cancer, hepatocellular carcinoma, and ovarian cancer, hepatocellular carcinoma and ovarian cancer.17, 18, 19